文献速递疼痛医学区域麻醉与超声

靶向硬膜外导管与标准C7-T1椎板间入路颈段硬膜外类固醇注射治疗单侧神经根性疼痛的前瞻性随机对照试验

A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain.
PubMed 文献 · Reg Anesth Pain Med · 2017-01-01

这项前瞻性随机单盲试验比较了靶向硬膜外导管推进至病变侧和节段与标准C7-T1椎板间入路行颈段硬膜外类固醇注射治疗单侧颈神经根性疼痛的疗效。结果显示两组在1个月时NRS、ONDI、PDI、MPQ、PGIC、DME及MQS III评分均无显著差异(P>0.05),但两组在疼痛、功能、残疾和药物使用等多个结局领域均观察到有临床意义的改善,并持续至6个月随访。

要点

  • 靶向硬膜外导管与标准C7-T1入路在1个月及6个月随访中临床结局无显著差异。
  • 两组均有较高比例患者达到NRS疼痛缓解≥50%和ONDI改善≥30%。
  • 两种技术均与疼痛、功能、残疾和药物使用方面的临床有意义改善相关。

核心结论

  • 对于C5或C6水平单侧颈神经根性疼痛,使用靶向硬膜外导管的颈段硬膜外类固醇注射与标准C7-T1入路相比,临床结局无显著差异。
  • 两种技术均与疼痛、功能、残疾和药物使用等多个结局领域的临床有意义改善相关,且效果持续至6个月随访。

研究设计与样本

  • 主要结局为1个月时NRS疼痛评分;次要结局包括ONDI、PDI、MPQ、PGIC、DME和MQS III评分。

主要发现

  • 1个月时,导管组26例(72%,95%CI 57%-87%)和非导管组23例(60%,95%CI 45%-75%)报告NRS降低≥50%。
  • 1个月时,导管组24例(67%,95%CI 52%-84%)和非导管组23例(58%,95%CI 42%-73%)报告ONDI降低≥30%。
  • 两组间中位NRS、ONDI、PDI、MPQ、PGIC、DME或MQS III评分均无差异(P>0.05),且在任何随访时间点均未观察到组间差异。

临床怎么用

  • 对于C5或C6水平单侧颈神经根性疼痛,标准C7-T1椎板间入路与靶向硬膜外导管推进至病变侧和节段均可作为颈段硬膜外类固醇注射的选项,两者临床疗效相当。
  • 两种技术均可带来疼痛、功能、残疾和药物使用方面的临床有意义改善,效果可持续至6个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: No study has compared cervical interlaminar epidural steroid injection (CIESI) with epidural catheter advancement to the side and level of pathology versus standard C7-T1 CIESI. This study investigated whether cervical radicular pain is more effectively treated by CIESI with a targeted epidural catheter versus a standard C7-T1 approach. METHODS: Prospective, randomized, single-blinded trial. PRIMARY OUTCOME: Numerical Rating Scale (NRS) pain at 1 month. SECONDARY OUTCOMES: Oswestry Neck Disability Index (ONDI), Pain Disability Index (PDI), McGill Pain Questionnaire (MPQ), Patient Global Impression of Change (PGIC), daily morphine equivalents (DME), and Medication Quantification Scale (MQS) III scores. RESULTS: Seventy-six participants with a median age of 48 years (IQR, 40-56 years), 59% female, with C4 (n = 2), C5 (n = 27), or C6 (n = 47) radicular pain were enrolled. At 1 month in the catheter and no catheter groups, respectively: 26 (72%, 95% confidence interval [CI], 57%-87%) and 23 (60%; 95% CI, 45%-75%) participants reported 50% or greater NRS reduction; 24 (67%; 95% CI, 52%-84%) and 23 (58%; 95% CI, 42%-73%) participants reported 30% or greater ONDI reduction. There were no group differences in median NRS, ONDI, PDI, MPQ, PGIC, DME, or MQSIII scores (P > 0.05). Intergroup differences were not observed at any follow-up interval. CONCLUSIONS: This trial showed no significant difference in clinical outcomes with CIESI using a targeted epidural catheter compared to a standard C7-T1 approach for the treatment of unilateral cervical radicular pain at the C5 or C6 level. Both techniques were associated with clinically meaningful improvement across outcome domains of pain, function, disability, and medication use. These effects persisted to 6-month follow-up.The study was registered at Clinical Trials.gov (NCT02095197).

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. McCormick ZL, Nelson A, Bhave M, et al. A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain. Reg Anesth Pain Med. 2017. PMID: 27922950. doi:10.1097/AAP.0000000000000521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。